Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear members, The 2024 CBS AGM will take place on May 28th at 7 30 PM EST. Please find here the link https mcgill...

Dear CBS member, This email concerns nominations for positions on the Board of Directors and proposals to host the 2026 Annual Meeting...

As part of its legacy strategy, the NanoMedicines Innovation Network NMIN is creating an online database of Canadian nanomedicines researchers and the areas of expertise represented within their labs...

Dear Trainees, Drs. Marcelo Munoz and Emilio Alarcon will facilitate a workshop on Peptide Synthesis and Applications in Regenerative Medicine at the University of Ottawa Heart Institute from August 14th to 17th, 2023...

On-demand drug release has great potential in post-surgical pain control, infection treatment, hormonal therapy, and chemotherapy...

Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...

Atherosclerotic vascular disease, including peripheral arterial disease PAD , is the leading cause of mortality in North America and Europe, with PAD accounting for 1 5 of all vascular disease...

Nanomedicine attempts to enhance the bioavailability of drugs and to reduce their side effects. Creation of functional hollow mesoporous naospheres HMNs could be desirable for biomedical applications since their hollow interior can be used as storage or nanoscale reactor while mesoporous shell providing the controlled uptake release role...

Cells in vivo are subjected to mechanical signals including deformations, external mechanical forces, and the stiffness of the extracellular matrix1...